Year |
Citation |
Score |
2023 |
Chapdelaine AG, Ku GC, Sun G, Ayrapetov MK. The Targeted Degradation of BRAF V600E Reveals the Mechanisms of Resistance to BRAF-Targeted Treatments in Colorectal Cancer Cells. Cancers. 15. PMID 38136350 DOI: 10.3390/cancers15245805 |
0.391 |
|
2023 |
Sun G, Ayrapetov MK. Dissection of the catalytic and regulatory structure-function relationships of Csk protein tyrosine kinase. Frontiers in Cell and Developmental Biology. 11: 1148352. PMID 36936693 DOI: 10.3389/fcell.2023.1148352 |
0.682 |
|
2022 |
Ku GC, Chapdelaine AG, Ayrapetov MK, Sun G. Identification of Lethal Inhibitors and Inhibitor Combinations for Mono-Driver versus Multi-Driver Triple-Negative Breast Cancer Cells. Cancers. 14. PMID 36011019 DOI: 10.3390/cancers14164027 |
0.484 |
|
2018 |
Huang C, Zhang Z, Chen L, Lee HW, Ayrapetov MK, Zhao TC, Hao Y, Gao J, Yang C, Mehta GU, Zhuang Z, Zhang X, Hu G, Chin YE. Acetylation within the N- and C-terminal domains of Src regulate distinct roles of STAT3-mediated tumorigenesis. Cancer Research. PMID 29531159 DOI: 10.1158/0008-5472.Can-17-2314 |
0.404 |
|
2007 |
Ahmadibeni Y, Hanley M, White M, Ayrapetov M, Lin X, Sun G, Parang K. Metal-binding properties of a dicysteine-containing motif in protein tyrosine kinases. Chembiochem : a European Journal of Chemical Biology. 8: 1592-605. PMID 17674392 DOI: 10.1002/Cbic.200700242 |
0.646 |
|
2006 |
Ayrapetov MK, Wang YH, Lin X, Gu X, Parang K, Sun G. Conformational basis for SH2-Tyr(P)527 binding in Src inactivation. The Journal of Biological Chemistry. 281: 23776-84. PMID 16790421 DOI: 10.1074/Jbc.M604219200 |
0.641 |
|
2006 |
Wang YH, Ayrapetov MK, Lin X, Sun G. A new strategy to produce active human Src from bacteria for biochemical study of its regulation. Biochemical and Biophysical Research Communications. 346: 606-11. PMID 16765913 DOI: 10.1016/J.Bbrc.2006.05.180 |
0.7 |
|
2006 |
Lee S, Ayrapetov MK, Kemble DJ, Parang K, Sun G. Docking-based substrate recognition by the catalytic domain of a protein tyrosine kinase, C-terminal Src kinase (Csk). The Journal of Biological Chemistry. 281: 8183-9. PMID 16439366 DOI: 10.1074/Jbc.M508120200 |
0.642 |
|
2005 |
Lin X, Ayrapetov MK, Sun G. Characterization of the interactions between the active site of a protein tyrosine kinase and a divalent metal activator. Bmc Biochemistry. 6: 25. PMID 16305747 DOI: 10.1186/1471-2091-6-25 |
0.693 |
|
2005 |
Ye G, Ayrapetov M, Nam NH, Sun G, Parang K. Solid-phase binding assays of peptides using EGFP-Src SH2 domain fusion protein and biotinylated Src SH2 domain. Bioorganic & Medicinal Chemistry Letters. 15: 4994-7. PMID 16169725 DOI: 10.1016/J.Bmcl.2005.08.005 |
0.616 |
|
2005 |
Ayrapetov MK, Nam NH, Ye G, Kumar A, Parang K, Sun G. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation. The Journal of Biological Chemistry. 280: 25780-7. PMID 15890649 DOI: 10.1074/Jbc.M504022200 |
0.653 |
|
2005 |
Lin X, Ayrapetov MK, Lee S, Parang K, Sun G. Probing the communication between the regulatory and catalytic domains of a protein tyrosine kinase, Csk. Biochemistry. 44: 1561-7. PMID 15683240 DOI: 10.1021/Bi048142J |
0.649 |
|
2003 |
Ayrapetov MK, Lee S, Sun G. Expression, purification, and biochemical characterization of Chk, a soluble protein tyrosine kinase. Protein Expression and Purification. 29: 148-55. PMID 12767803 DOI: 10.1016/S1046-5928(02)00698-8 |
0.668 |
|
Show low-probability matches. |